Steen Lyders Wadskov
4 IP cases indexed. Covers patent matters.
Cases Presided Over
4 cases indexed | Page 1 of 1
Pfizer Inc. and others v.GlaxoSmithKline Biologicals SA
This procedural order concerns revocation proceedings before the Milan Central Division of the Unified Patent Court regarding EP 4 183 412 (RSV F protein compositions). Following the parties' joint request, the court allowed the withdrawal of the revocation action and counterclaim for revocation filed by Pfizer against GlaxoSmithKline Biologicals SA, declared the proceedings closed, and ordered reimbursement of 60% of the court fees to the claimants/counterclaimants.
Pfizer Inc. and others v.GlaxoSmithKline Biologicals SA
This procedural order from the Central Division Milan of the Unified Patent Court concerns the withdrawal of a revocation action and counterclaim for revocation filed by various Pfizer entities against GlaxoSmithKline Biologicals SA regarding EP 4 183 412 (RSV F protein compositions). Both parties jointly requested the withdrawal, which the court allowed, declared the proceedings closed, and ordered reimbursement of 60% of the court fees to the Claimants/Counterclaimants, with no cost decision required.
Pfizer Inc. and others v.GlaxoSmithKline Biologicals SA
This procedural order concerns a revocation action filed by multiple Pfizer entities against GlaxoSmithKline Biologicals SA regarding EP 4 183 412 (RSV F protein compositions). Prior to closure of the written procedure, Pfizer requested withdrawal of both the revocation action and its counterclaim for revocation, with Glaxo's consent. The court allowed the withdrawal, declared the proceedings closed, ordered no cost decision, and directed reimbursement of 60% of the court fees to Pfizer.
Pfizer Inc. and others v.GlaxoSmithKline Biologicals SA
This procedural order concerns a revocation action filed by multiple Pfizer entities against GlaxoSmithKline Biologicals SA regarding European Patent EP 4 183 412 (RSV F protein compositions). Prior to the closure of the written procedure, Pfizer requested withdrawal of the revocation action and counterclaim for revocation, with reimbursement of 60% of court fees, and Glaxo consented. The Court allowed the withdrawal, declared the proceedings closed, ordered reimbursement of 60% of court fees, and set the value in dispute at more than EUR 50,000,000.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.